Nasdaq Bumps DeCode from Global Market | GenomeWeb

NEW YORK (GenomeWeb News) — DeCode Genetics' stock has been moved from the Nasdaq Global Market to the Nasdaq Capital Market after failing to maintain a minimum market value for listed shares, the company said today.

Nasdaq decided to move DeCode to the Capital Market, which is one of three Nasdaq tiers, after a review hearing on Dec. 18, 2008, regarding its non-compliance with the market's rules.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.